Because of the common underlying pathomechanisms, severe asthma and nasal polyposis can be successfully treated together by the same monoclonal antibodies, targeting IgE, type 2 cytokines, or their receptors (Figure 1). This evidence concerns the gene IGHE and Nasal polyposis.